Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of KCT-0809 in Dry Eye with Sjögren's Syndrome
NCT02503176Phase 3Terminated
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ozagrel in dry eye syndrome (DED), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: terminated.
02
Drugs
ozagrel
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02503176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503176.